Today the drugstore chain reported its Q3 results, the first since David Joyner became CEO. The latest earnings report showed that CVS anticipates elevated medical costs will continue to affect the company for the rest of the financial year.
“Establishing credibility and earning the trust of our investors is one of my top priorities as the new leader of CVS Health,” Joyner said in a statement. “To achieve that, any guidance we provide should be achievable, with clear opportunities for outperformance. This is a core principle for me.”
Joyner admitted that the company continues to struggle to get back to where it was, prior to 2020. “While the entire industry has seen elevated utilization coming out of the pandemic, we have been more acutely impacted than others,” Joyner said. “Our immediate priority remains ensuring the stability of the business.”
Company stocks rose by 6 percent in premarket trading today. However, the shares of the company are down nearly 27% for the year. Joyner recognizes that its health insurance unit, Aetna, is heavily affecting profits as customers are returning to hospitals to undergo delayed procedures. These pre-pandemic policies are projected to continue to affect CVS’s cash flow for 2025.
Today, the company announced new hires, with Prem Shah appointed as Group President and Steve Nelson as President of Aetna. Both appointments are effective immediately.
“Prem is a strong operator and innovator with deep experience across our businesses, and in his role, he will help me and the rest of our leadership team drive improvements in our financial and operational performance across our company,” said Joyner. “I am confident in the future of our integrated model, and that Prem and Steve’s leadership will help further position us to deliver greater value from our integrated business model.”
By CEO NA Editorial Staff
